Agile Therapeutics Shares Outstanding 2013-2018 | AGRX

Current and historical number of shares outstanding for Agile Therapeutics (AGRX) from 2013 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Agile Therapeutics Annual Shares Outstanding
(Millions of US $)
2017 $31
2016 $28
2015 $22
2014 $11
2013 $0
2012 $0
Agile Therapeutics Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $34
Q1 2018 $34
Q4 2017 $31
Q3 2017 $32
Q2 2017 $29
Q1 2017 $29
Q4 2016 $28
Q3 2016 $29
Q2 2016 $29
Q1 2016 $27
Q4 2015 $22
Q3 2015 $22
Q2 2015 $22
Q1 2015 $21
Q4 2014 $11
Q3 2014 $19
Q2 2014 $8
Q1 2014 $1
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q4 2012 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.009B $0.000B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $62.458B 10.72
Teva Pharmaceutical Industries (TEVA) Israel $22.859B 6.39
Mylan (MYL) United Kingdom $19.184B 8.16
Bausch Health Cos (BHC) Canada $7.619B 5.69
Dr Reddy's Laboratories (RDY) India $5.346B 23.88
Mallinckrodt Public (MNK) United Kingdom $2.588B 4.40
Supernus Pharmaceuticals (SUPN) United States $2.410B 25.78
Akorn (AKRX) United States $2.332B 11.55
Assembly Biosciences (ASMB) United States $1.006B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.801B 115.47
CymaBay Therapeutics (CBAY) United States $0.714B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.628B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.613B 0.00
Voyager Therapeutics (VYGR) United States $0.589B 0.00
Homology Medicines (FIXX) United States $0.582B 0.00
Corium (CORI) United States $0.314B 0.00
Teligent (TLGT) United States $0.220B 0.00
Sol-Gel Technologies (SLGL) Israel $0.124B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.115B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.073B 0.00
Versartis (VSAR) United States $0.063B 0.00
Aevi Genomic Medicine (GNMX) United States $0.058B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.023B 0.00
Acasti Pharma (ACST) Canada $0.019B 0.00